Identified variants in genes such as UGT1A7, PYCR1, LZTR1, and FAT1, which are involved in metabolic pathways, chemical carcinogenesis, MAPK signalling, and Wnt signalling, point to novel contributors to CRC in this understudied population [24–27]. Here, FAT1 is linked to colorectal carcinoma.